Organogenesis Holdings Inc reports results for the quarter ended in March - Earnings Summary

Organogenesis Holdings

10/05/2024 24:25

* Organogenesis Holdings Inc  ORGO.OQ  reported a quarterly
adjusted loss of 2 cents​​ per share for the quarter ended in
March, identical to the same quarter last year.  The mean
expectation of three analysts for the quarter was for a loss
of 3 cents per share. Wall Street expected results to range from
-4 cents to -1 cents per share.
    * Revenue rose 2.2% to $109.98 million from a year ago;
analysts
expected $101.05 million. 
    * Organogenesis Holdings Inc's reported EPS for the quarter
was a
loss of 2 cents​.
    * The company reported a quarterly loss of $2.1 million.
    * Organogenesis Holdings Inc shares had fallen by 18.7% this
quarter and lost 43.5% so far this year.

FORECAST CHANGES
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * Wall Street's median 12-month price target for
Organogenesis
Holdings Inc is $5.00 

This summary was machine generated from LSEG data May 9 at 11:25
p.m. UTC. ​All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.03          -0.02          Beat
 Dec. 31 2023      0.01           0.00           Missed
 Sep. 30 2023      0.01           0.02           Beat
 Jun. 30 2023      0.03           0.04           Beat